Avsnitt

  • Nonfiction Laboratories is building a technology called “magnetogenetics” that promises to control proteins inside the body — such as antibodies or enzymes — using small magnets. In this episode, co-founder Maria Ingaramo and scientific advisor Andrew York explain how they engineered a protein, MagLOV, that responds strongly to magnetic fields, why most prior attempts have failed to replicate, and how the mechanism of magnetically-controlled proteins actually works. They also get into the “dream” use cases, like cancer drugs that activate only at the tumor, which might have a lower toxicity inside the body.

    This podcast is made possible by Astera Institute.

    Notes from our discussion: https://nikomc.com/essays/protein-magnets.html

    00:00 - Opening

    00:54 — Introduction

    01:35 — The dream

    05:38 — Why magnets vs. light or ultrasound

    10:05 — The physics

    17:48 — On the name "magnetogenetics"

    21:25 — Birds and cryptochromes

    27:09 — Why is the field filled with so much junk?

    29:51 — Adam Cohen's molecule

    33:24 — Markus Meister’s debunking

    38:06 — The experiment

    46:22 — Finding the LOV domain

    54:11 — Singlets, triplets, and cysteine

    56:54 — What the magnet is actually doing

    1:05:13 — The conformational-change red herring

    1:12:46 — The Quantum Biology Institute

    1:19:31 — Founding Nonfiction Labs

    1:24:38 — How to convince skeptical investors

    1:29:39 — What a magnetogenetic medicine might look like

    1:38:50 — First clinical indications

    1:45:12 — The regulatory path

    1:48:01 — What the field needs

    1:54:30 — Appendix: Whiteboard lecture

  • Plasmidsaurus took plasmid sequencing from $600 to $15 and turned a "boring" service company idea into a hugely successful company serving 70,000+ scientists. In this episode, CEO Mark Budde and Niko McCarty get into the bigger question: what does it take for companies to automate and scale wet-lab biology methods in the same way that Plasmidsaurus did for sequencing? They cover the early Oxford Nanopore bet, the obsession with speed, and why Mark won’t sell customer data to AI labs.

    This podcast is made possible by Astera Institute.

  • Saknas det avsnitt?

    Klicka här för att uppdatera flödet manuellt.